Myeloproliferative Neoplasms: Integrating New Therapies Into Challenging Case Scenarios

Myeloproliferative Neoplasms: Integrating New Therapies Into Challenging Case Scenarios
Myeloproliferative Neoplasms: Integrating New Therapies Into Challenging Case Scenarios
CME, CPE, CNE
Prithviraj Bose, MD – Chair; Ruben Mesa, MD; Raajit K. Rampal, MD, PhD
Release Date: September 14, 2020
Expiration Date: September 14, 2021

Management of myeloproliferative neoplasms has evolved considerably since the identification of JAK2 and targeted therapy that has improved disease-related symptoms and quality of life. Our renowned faculty will provide updates in the latest data related to diagnosis, treatment options, guidelines, and standards of care through a highly interactive educational experience. Three real-life case scenarios will be presented, and the faculty will discuss treatment options and the journey of each patient.

This activity was previously presented as a webinar with live Q&A in September of 2020. Please note: If you participated in the live webinar, you are ineligible to receive an additional 1.25 contact hours of credit and may not re-submit for credit previously awarded.

Provided by MediCom Worldwide, Inc.
This activity is supported by educational grants from Bristol-Myers Squibb and Incyte Corporation.
Begin, Earn CreditView Only, No CreditGet Certificate